Thursday, December 26, 2024
Home 2023 September

Monthly Archives: September 2023

Psychedelic Stock Review

Adding Cybin (CYBN) $0.46 to 2024 Top Psychedelic Stocks Watch List.

Editor / Curator -
Stand Down

Short Selling Contest | Enter by September 30th.

Editor / Curator -
All News

ENDRA Life Science’s (NDRA) $1.23 Fatty Liver Detector Advances to Next...

Editor / Curator -
Biotech News

Is Citius Pharma a Ten Bagger?

Editor / Curator -
All News

Billions Lost in These Two Healthcare Spacs.

Editor / Curator -
NTTS

New to the Street | Newsmax TV | Episode 508

Editor / Curator -
Zappy Zapolin, Chad Harman, Kevin Harrington, Psychedelic Stock Review
2023 Watch List

Psycheceutical’s (BWVI) Delivery Tech is Grabbing Attention. Will Pharma Listen?

Editor / Curator -
DarioHealth,
2023 Watch List

Plansource Invites DarioHealth (DRIO) Into 50 Broker Partnership Network, Serving 5...

Editor / Curator -
SEKER, INTERNETSTOCKREVIEW
AI Artificial Intelligence

NYC Woman says she Lost Over $740K After her Lawyer’s Email...

Editor / Curator -
AI Artificial Intelligence

Sekur (SWISF) Advances as Secure Communications Become Vital Against Breaches and...

Editor / Curator -
123Page 2 of 3

Latest article

Adding Quantum Pharmaceutical (QNTM) $4.10 to Reverse Split Stock Watch List.

All News Editor / Curator -
119% Gain Post Split

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.